Please login to the form below

Not currently logged in
Email:
Password:

Pfizer’s Alan Maine moves to Edelman

He joins the communications firm as its senior director

Alan MaineGlobal communications and marketing firm Edelman has strengthened its health public affairs capabilities with the addition of Alan Maine, who joins as its senior director.

Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area public affairs.

During his time at Pfizer, Maine also worked with industry associations on campaigns, policies and initiatives relating to access to medicines.

He said: “I am delighted to be working with such a forward-looking company as Edelman and I am thrilled to work with the team to deliver innovative and strategic campaigns.”

Prior to his time with Pfizer, Maine was head of government affairs at Wyeth Pharmaceuticals - later acquired by Pfizer - and has held other roles with Merck Sharpe & Dohme.

Kate Hawker, managing director for Edelman UK, said: “We are very excited about Alan joining Edelman as he brings with him such great knowledge and insight of the complex challenges in the UK.”

5th February 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics